Daniel Pichl - 08 Sep 2021 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role: Chief People Officer
Signature: /s/ Francis I. Perier, Jr as Attorney-in-Fact
Issuer symbol: SWTX
Transactions as of: 08 Sep 2021
Net transactions value: +$99,992
Form type: 4
Filing time: 09 Sep 2021, 17:15:49 UTC
Next filing: 10 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWTX	Common Stock	Options Exercise	$99,992	+2,320	+34%	$43.10	9,236	08 Sep 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWTX	Stock Option (Right to Buy)	Options Exercise	$0	-2,320	-3.1%	$0.000000	72,680	08 Sep 2021	Common Stock	2,320	$43.10	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option exercises reported on this Form 4 reflect cash exercises of such options awarded under the issuer's employee equity incentive plan, to purchase common stock by the reporting person. No shares were subsequently sold by the reporting person.
F2	Includes 4,150 restricted stock awards which are subject to forfeiture until they vest.
F3	Twenty-five percent (25%) of the original amount of options granted to the reporting person on August 3, 2020 vested on the first anniversary of August 3, 2020, and the remaining seventy-five percent (75%) of such options began to vest, and will continue to vest, in 36 equal monthly installments thereafter, subject to continued service to the issuer by the reporting person.